跳转至内容
Merck
CN
  • Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery.

Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery.

Tissue engineering. Part A (2014-01-15)
Zeeshan H Syedain, Lee A Meier, Mathew T Lahti, Sandra L Johnson, Robert T Tranquillo
摘要

The performance of completely biological, decellularized engineered allografts in a sheep model was evaluated to establish clinical potential of these unique arterial allografts. The 4-mm-diameter, 2-3-cm-long grafts were fabricated from fibrin gel remodeled into an aligned tissue tube in vitro by ovine dermal fibroblasts. Decellularization and subsequent storage had little effect on graft properties, with burst pressure exceeding 4000 mmHg and the same compliance as the ovine femoral artery. Grafts were implanted interpositionally in the femoral artery of six sheep (n=9), with contralateral sham controls (n=3). At 8 weeks (n=5) and 24 weeks (n=4), all grafts were patent and showed no evidence of dilatation or mineralization. Mid-graft lumen diameter was unchanged. Extensive recellularization occurred, with most cells expressing αSMA. Endothelialization was complete by 24 weeks with elastin deposition evident. These completely biological grafts possessed circumferential alignment/mechanical anisotropy characteristic of native arteries and were cultured only 5 weeks prior to decellularization and storage as "off-the-shelf" grafts.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
单克隆抗 β-肌动蛋白抗体 小鼠抗, clone AC-15, ascites fluid
Sigma-Aldrich
抗肌动蛋白,α-平滑肌抗体,小鼠单克隆, clone 1A4, purified from hybridoma cell culture
Sigma-Aldrich
抗 CD3,T 细胞 兔抗, whole antiserum